Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220014871 220015032 null 67.5 Curative (C) 2015-07-16 2015-07-16 FIGARO TRIAL N N 220035982 CAPECITABINE
220014872 220009487 1.65 84.4 Palliative (P) 2015-12-31 2015-12-31 Cisplatin 02 N 220036006 ECF
220014873 220009488 1.77 71.8 Palliative (P) 2014-03-23 2014-04-01 Midostaurin N N 220036006 UKALL 2011
220014874 220009489 1.57 87.2 Curative (C) 2015-03-16 2015-03-16 Folfirinox N N 220036013 EOX
220014875 220009489 1.49 48.7 Palliative (P) 2015-07-18 2015-07-31 Eribulin 2 N 220036013 CYTARABINE + MITOXANTRONE
220014876 220009490 1.67 80.7 null 2014-10-21 2014-10-21 Pazopanib N N 220036034 NIVOLUMAB
220014877 220009494 1.73 84.5 Palliative (P) 2014-09-26 2014-10-12 CARBOPLATIN 2 N 220036036 EOX
220014878 220015037 null 0 Palliative (P) 2013-11-22 2013-12-12 Gemcitabine 1000mg/m2 D1 8 15 2 N 220036041 DOCETAXEL + GEMCITABINE
220014879 220015037 1.62 78.4 null 2017-09-16 2017-09-24 Mercaptopurine 02 N 220036041 RAVVA TRIAL
220014880 220015037 1.56 0 Palliative (P) 2015-05-10 2015-05-10 FLUOROURACIL + MITOMYCIN 02 N 220036041 CETUXIMAB + IRINOTECAN + MDG
220014881 220009496 1.6 null Palliative (P) 2017-01-11 2017-01-15 TRASTUZUMAB Y N 220036056 CISPLATIN + ETOPOSIDE
220014882 220009497 1.72 76.6 Palliative (P) 2015-10-21 2015-10-28 CAPECITABINE + OXALIPLATIN 2 N 220036057 RALTITREXED
220014883 220009497 null null null 2016-08-09 2016-08-21 CISPLATIN + RT N N 220036057 MIDAC
220014884 220009499 1.59 null null 2014-06-25 2014-06-30 BUSULFAN + CYCLO 2 N 220036061 IPILIMUMAB
220014885 220009500 1.41 51.5 Palliative (P) 2014-10-28 2014-11-24 Gemcitabine weekly N N 220036062 FCR
220014886 220009501 1.96 118.5 Palliative (P) 2017-08-05 2017-08-19 CAMELLIA Trial N N 220036071 DABRAFENIB + TRAMETINIB
220014887 220009502 1.75 null Not known (9) 2016-05-01 2016-05-01 CISPLATIN + RT N N 220036081 IPILIMUMAB
220014888 220009502 1.79 66 Disease modification (D) 2015-11-09 2015-12-03 MidAC 1 N 220036081 ETOPOSIDE
220014889 220009503 1.62 64.6 Palliative (P) 2014-01-01 2014-01-04 Alemtuz+Cyclophos+Fludara Allo 2 N 220036088 MERCAPTOPURINE + METHOTREXATE
220014892 220009505 1.67 85.1 Disease modification (D) 2014-03-23 2014-04-06 RAVVA TRIAL N N 220036098 ERLOTINIB
220014893 220009506 null 66.7 Palliative (P) 2016-03-29 2016-05-14 Alemtuzumab+Busulfan+CyclophosphMUD N N 220036098 CETUXIMAB + IRINOTECAN + MDG
220014896 220009508 1.84 null Curative (C) 2015-03-27 2015-05-09 Fluorouricil + Folonic Acid (MdG) N N 220036121 CAPECITABINE
220014897 220009514 null null Adjuvant (A) 2013-10-23 2013-10-31 Carboplatin AUC 2 - 5 null null 220036144 CYTARABINE + FLUDARABINE + IDARUBICIN
220014899 220009518 1.84 79 Palliative (P) 2016-11-08 2016-11-15 Busulfan Oral 2 N 220036150 GEMCITABINE
220014900 220009520 1.56 78.6 null null 2015-09-19 Carboplatin AUC 2 - 5 N N 220036156 CAPECITABINE
220014901 220009521 null null Palliative (P) 2013-08-14 2013-08-14 FIGARO TRIAL null null 220036162 CVD
220014902 220009521 null null Palliative (P) 2016-03-16 2016-04-27 IBRUTINIB 99 N 220036162 CHOP
220014904 220015049 1.61 null Disease modification (D) 2015-05-08 2015-05-15 IVE N N 220036169 CAPECITABINE + CARBOPLATIN
220014905 220009523 1.64 48.8 Curative (C) 2014-07-26 2014-07-26 Ipilimumab 1 N 220036174 SORAFENIB
220014906 220015050 1.91 96 Palliative (P) 2017-12-01 2017-12-10 Temozolomide 150mg/m2 N N 220036180 LIPOSOMAL CYTARABINE
220014907 220019991 null null Curative (C) 2017-01-19 2017-01-19 VIDE N null 220036184 CARBOPLATIN
220014908 220019991 1.62 52.2 Palliative (P) 2013-12-17 2013-12-17 CETUXIMAB N N 220036184 CAPECITABINE
220014909 220019991 1.67 80.3 Disease modification (D) 2017-01-06 2017-01-06 IGEV R N null 220036184 PAD
220014910 220009524 1.83 84 Palliative (P) 2014-07-17 2014-07-17 Bevacizumab + CARBOPLATIN + PACLITAXEL 02 N 220036196 MITOXANTRONE + TRETINOIN
220014911 220015051 null null Disease modification (D) 2018-04-26 2018-04-27 VINCRISTINE N null 220036201 DAUNORUBICIN
220014912 220009525 1.55 0 Not known (9) 2015-07-31 2015-08-14 MERCAPTOPURINE + METHOTREXATE + VINCRISTINE N N 220036202 CETUXIMAB + RT
220014914 220009528 1.58 null Not known (9) 2014-08-10 2014-08-20 Gemcitabine weekly null N 220036215 BORTEZOMIB
220014915 220009530 2 68.6 null 2015-12-25 2015-12-25 PEMBROLIZUMAB 02 N 220036215 TRASTUZUMAB
220014916 220009531 1.67 54 Palliative (P) 2016-01-21 2016-01-27 Liposomal Doxorubicin (Caelyx) N Y 220036225 ETOPOSIDE
220014917 220009533 1.59 77.2 Palliative (P) 2017-08-30 2017-09-16 Cisplatin N N 220036225 CARBOPLATIN
220014918 220009535 1.82 69.1 Disease modification (D) 2015-03-15 2015-03-21 Cisplatin 7 day Y N 220036229 CAP
220014919 220009535 1.69 33.4 Palliative (P) 2014-12-08 2014-12-12 Arsenic Trioxide (Induction Week) N null 220036229 FIGARO TRIAL
220014920 220009536 null null Palliative (P) 2017-07-14 2017-07-14 Alemtuzumab+Busulfan+CyclophosphMUD N null 220036230 FLUDARABINE
220014921 220009538 1.7 81.9 Palliative (P) 2017-02-26 2017-03-03 MACE 02 N 220036240 LI-1 TRIAL
220014922 220015060 1.78 79 Palliative (P) 2015-03-23 2015-03-29 EEF or EOF 02 N 220036241 BENDAMUSTINE + RITUXIMAB
220014923 220009540 0 68.4 Disease modification (D) null 2015-07-28 CISPLATIN + METHOTREXATE + VINCRISTINE N N 220036243 BEP
220014924 220009541 1.75 86.2 Curative (C) 2015-12-04 2015-12-04 Packer Induction Vincristine + RT N N 220036245 CARBOPLATIN
220014925 220009541 null 78.5 Palliative (P) 2018-08-20 2018-09-10 Paclitaxel+Trastuzumab 21day Load 02 null 220036245 BORTEZOMIB
220014926 220009542 1.69 94 Palliative (P) 2015-08-03 2015-08-03 CHOP R - 21 days N N 220036248 MACE
220014927 220009543 null null Disease modification (D) null 2017-07-06 Arsenic Trioxide (Induction Week) null null 220036269 CAPECITABINE